Upcoming catalysts and material SEC filings for Celldex Therapeutics, Inc. (CLDX). 1 upcoming catalyst.
Trial readout (estimated)
Q4 2026 · Estimated — subject to change
Extracted from the company's SEC 8-K filings (EDGAR). Estimated dates can change.
No recent filings for CLDX.